Zoom or in person

We assist health tech investors in de-risking their investment choices by providing a clear and easy-to-understand report, outlining regulatory, technological, and clinical aspects of the technology.
Our exhaustive assessments revolve around three pivotal factors crucial for successful investments:
Unmet Clinical Need Fulfillment: The failure of most MedTech ventures can be attributed to their inability to solve a genuine clinical issue. Our team has over ten years of clinical experience and is trained to identify unmet clinical needs systematically.
Intellectual Property Assessment: We provide a thorough analysis to ascertain the novelty, usefulness and non-obviousness of the MedTech assets, which is crucial for safeguarding your investment in the MedTech sector.
Competitive Positioning Analysis: We provide insights into the competitive landscape, analyzing market size and assessing the alignment of providers and payers.
MedGeist can review your development programme and advise you on:
If you are investing in or developing a medical device or a diagnostic test, MedGeist can help by:
If you developed or commissioned an economic model for submission to an HTA agency or in-house analyses MedGeist can:
MedGeist works with investors in health technologies and developers of medicines, medical devices, diagnostics, and digital solutions. Our team possesses a robust foundation and experience in clinical practice, research, and commercialization of healthcare products in the US, UK, and Europe.
Our objective is to provide:
1. Introduction to HTA: Pharmaceuticals.
2. Introduction to HTA: Medical Devices.
3. Introduction to Health Economics.
4. Introduction to Clinical Trials and how to ensure you meet stakeholder requirements
5. HTA in Europe